Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
THC
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
165.00(35.14%)
Number of analyst
1
Last analyst upgrade/downgrade
Morgan Stanley
initialisePrevious: Not converted
2025-03-26
Now: Overweight
Goldman Sachs
downgradePrevious: Buy
2024-12-16
Now: Neutral
KeyBanc
initialisePrevious: Not converted
2024-10-10
Now: Overweight
Wolfe Research
upgradePrevious: Not converted
2024-03-27
Now: Outperform
Earnings Growth
YoY
Current
Estimates
Q1.23
-26%
1.42
vs 1.93
Q2.23
-4%
1.44
vs 1.5
Q3.23
N/A
1.44
vs 1.44
Q4.23
+37%
2.68
vs 1.96
Q1.24
+127%
3.22
vs 1.42
Q2.24
+60%
2.31
vs 1.44
Q3.24
+103%
2.93
vs 1.44
Q4.24
+28%
3.44
vs 2.68
Q1.25
-3%
3.12
vs 3.22
Q2.25
+15%
2.66
vs 2.31
Sales Growth
YoY
Current
Estimates
Q1.23
+6%
5B vs 4.7B
Q2.23
+10%
5.1B vs 4.6B
Q3.23
+6%
5.1B vs 4.8B
Q4.23
+8%
5.4B vs 5B
Q1.24
+7%
5.4B vs 5B
Q2.24
+0%
5.1B vs 5.1B
Q3.24
+1%
5.1B vs 5.1B
Q4.24
-6%
5.1B vs 5.4B
Q1.25
-4%
5.1B vs 5.4B
Q2.25
+1%
5.1B vs 5.1B
Return on Equity
QoQ
Q1.23
+24%
0.24
vs 0.24
Q2.23
+9%
0.09
vs 0.24
Q3.23
+7%
0.07
vs 0.09
Q4.23
+15%
0.15
vs 0.07
Q1.24
+62%
0.62
vs 0.15
Q2.24
+7%
0.07
vs 0.62
Q3.24
+12%
0.12
vs 0.07
Q4.24
+8%
0.08
vs 0.12
Institutionnal Ownership
QoQ
Q1.23
392
392
vs 397
-1%
Q2.23
450
450
vs 392
15%
Q3.23
444
444
vs 450
-1%
Q4.23
467
467
vs 444
5%
Q1.24
496
496
vs 467
6%
Q2.24
571
571
vs 496
15%
Q3.24
642
642
vs 571
12%
Q4.24
628
628
vs 642
-2%
zacks.com
10 hours ago
zacks.com
10 hours ago
zacks.com
10 hours ago
zacks.com
13 hours ago
zacks.com
19 hours ago